dexamethasone,daratumumab,lenalidomide
janssen
['maia']
 presented today the maia analysis looking at frailty and qol: the gap between patients included in clinical trials and real-life patients is the big elephant in the room! #ash22 
Professor and head of Hematology Sorbonne Univ.; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.